Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

A Phase 1/2a Study of ALY688 Ophthalmic Solution in Dry Eye Subjects

Kenneth Sall; Gary Foulks; Stephen C Pflugfelder; David Evans; Philip Shettle; Jeanette Stewart; Henry Hsu

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3959.

ARVO Annual Meeting Abstract July 2019

Effects of ALY688 on Atropine-Induced Dry Eye in Rabbits

Kathryn S Crawford; Carter Schuh; Jordan Schuh; Henry Hsu

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):305.

ARVO Annual Meeting Abstract July 2018

Therapeutic Efficacy of Topical Adiponectin-Derived Short Peptides and Globular Adiponectin after alkali burn

Ying Li; Ru Jun Jin; Jung-Han Choi; Henry Hsu; Laszlo Otvos; Eva Surmacz; Kyung Chul Yoon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3838.

ARVO Annual Meeting Abstract June 2017

Therapeutic Efficacy of Topical Adiponectin-Derived Short Peptides and Globular Adiponectin for Experimental Dry Eye

Ying Li; Lian Cui; Hyo Seok Lee; Henry H Hsu; Laszlo Otvos; Eva Surmacz; Kyung Chul Yoon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):474.

ARVO Annual Meeting Abstract March 2012

Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS8535 in vivo

Barbara M. Wirostko; Hiroshi Umeno; Henry Hsu; Muralitharan Kengatharan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5079.

ARVO Annual Meeting Abstract March 2012

Pharmaceutical Profile of a Novel Rho Kinase (ROCK) inhibitor ATS8535 for Reduction of IOP in Glaucoma

Muralitharan Kengatharan; Hiroshi Umeno; Barbara Wirostko; Henry Hsu

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5081.

ARVO Annual Meeting Abstract April 2011

Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys

Barbara M. Wirostko; H Umeno; Henry H. Hsu; Muralitharan Kengatharan

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3096.

ARVO Annual Meeting Abstract April 2011

Pharmaceutical Profile Of A Novel Rho Kinase (ROCK) Inhibitor ATS907 For Reduction Of IOP In Glaucoma

Muralitharan Kengatharan; Barbara M. Wirostko; H Umeno; Henry H. Hsu

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3106.

ARVO Annual Meeting Abstract April 2011

Tolerability and IOP Lowering Activity of a Topical Rho Kinase Inhibitor, ATS907, in Normotensive Rabbits

Henry H. Hsu; Muralitharan Kengatharan; H Umeno; Barbara M. Wirostko

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3109.

Advertisement